The oversubscribed round was led by Bosch Ventures with backing from Porsche SE and British Patient Capital.
"The support of leading technology investors enables us to realise our vision of a quantum computer built using standard foundry processes. This support, along with the continuing UK national quantum programme and European initiatives, provides a step-change in our capabilities. We have assembled a world leading team and with the funding and support in place, we are ready to scale and deliver on our vision."
The Southampton developer has completed a Series A round led by Foresight Ventures following its recent product launch at CES.
"We would like to welcome our new investors to Audioscenic and would also like to say a huge thank you to our existing investors for their past and continued support"
AlbionVC led the investment round with participation from IP Group, Parkwalk, Hostplus, and Oxford Technology and Innovations EIS Fund.
"Citi Markets uses its deep software expertise to move faster and be more competitive. We find value in Diffblue’s auto-generation of test cases, which helps drive test consistency and coverage of our software. This frees up developers to focus on delivering higher quality software, faster – and improves our developers’ experience,"
The financing round was co-led by Lansdowne Partners, Oxford Science Enterprises, and Parkwalk Advisors.
"Global agriculture needs a new Green Revolution if we are to feed the world sustainably. Being able to control weeds is critical to both yield and the cost of production in most crops and new herbicide modes of action are essential. It’s very exciting to see moa starting to play its part in this new revolution by advancing so far in such little time."
The digital healthcare start-up secured backing from IP Group and Parkwalk Advisors to scale operations in Europe and the US.
"However, due to resource costs and poor logistics, current health systems cannot deliver the amount of therapy needed, with significant backlogs, and few patients receiving anywhere near what they require to get better. This is a common problem faced by hundreds of millions of patients around the world, with inefficient care pathways not only costing health systems hundreds of billions of dollars every year, but costing people a chance to live their lives to their full potential."
